Post-stroke Spasticity of the Upper Limb
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Post-stroke Spasticity of the Upper Limb trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Post-stroke Spasticity of the Upper Limb trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Patients after stroke with upper limb spasticity treated with botulinum toxin-A (BTX-A) will be included in this two-part study. In the first part, goal attainm…
The purpose of the study is to assess the safety and efficacy of increasing doses of IPN10200 with the aim to evaluate the Pharmacodynamics (PD) profile of IPN1…
Post-stroke upper limb spasticity is an important condition that negatively affects motor recovery, upper limb functions, and activities of daily living. Multim…
Introduction A large number of stroke patients develop spasticity in the upper and lower extremities, which is one of the clinical signs of damage to motor neur…